Related Experiment Videos
Cerebral small vessel disease: how does it progress?
Klaus Schmidtke1, Michael Hüll
1Center for Geriatric Medicine and Gerontology, University Clinic Freiburg, Lehener Str. 88, 79106 Freiburg, Germany. schmidtk@zggf.ukl.uni-freiburg.de
Journal of the Neurological Sciences
|March 12, 2005
Summary
Small vessel disease (SVD) progression impacts cognitive function and neurological deficits. Research is needed to understand SVD
Area of Science:
- Neurology
- Neuroimaging
- Vascular Dementia Research
Background:
- Small vessel disease (SVD), or cerebral microangiopathy, is a key cause of vascular dementia (VD).
- SVD presents with cognitive decline, neurological deficits, and emotional disturbances, and is common in healthy and mildly impaired individuals.
- Imaging detects SVD, but differentiating it from mixed SVD/Alzheimer's Disease is challenging.
Purpose of the Study:
- To review evidence on the progression rate and predictors of SVD.
- To examine SVD's impact on cognitive deficits, functional decline, and white matter lesions.
- To inform future research directions and outcome measures for SVD.
Main Methods:
- Review of epidemiological, clinical, and imaging studies on SVD progression.
- Analysis of data from placebo arms of vascular dementia drug trials.
- Synthesis of evidence regarding cognitive, functional, and imaging markers of SVD progression.
Main Results:
- SVD has an inherent tendency to progress, affecting cognition and function.
- Data on the natural course and progression predictors of SVD are limited.
- Few drug trials specifically target SVD progression.
Conclusions:
- Further research is essential to elucidate the natural history and progression of SVD.
- Standardized outcome measures are needed for future SVD clinical trials.
- Understanding SVD progression is critical for managing vascular dementia.